Clinical Trial Detail

NCT ID NCT01835223
Title Tivozanib in Treating Patients With Liver Cancer That is Metastatic or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Roswell Park Cancer Institute
Indications

hepatocellular carcinoma

Therapies

Tivozanib

Age Groups: adult

No variant requirements are available.